IGC Pharma
0.2504
+0.0020
+0.81%
IGC
02-06 16:10:00(美东时间)
高
0.2599
开
0.2470
量
43.84万股
总市值
2399.28万
低
0.2420
换
0.46%
额
10.92万
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
IGC Pharma(IGC)
02-05 06:35
$IGC Pharma(IGC)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-26-000411 Size: 9 KB
网页链接
IGC Pharma(IGC)
01-21 05:05
$IGC Pharma(IGC)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-26-000218 Size: 7 KB
网页链接
IGC Pharma(IGC)
01-06 19:06
$IGC Pharma(IGC)$
424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001185185-26-000030 Act: 33 Size: 304 KB
网页链接
IGC Pharma(IGC)
01-06 19:06
$IGC Pharma(IGC)$
8-K Current report, items 1.01 and 9.01 Accession Number: 0001185185-26-000032 Act: 34 Size: 305 KB
网页链接
IGC Pharma(IGC)
01-03 05:05
$IGC Pharma(IGC)$
8-K Current report, item 5.03 Accession Number: 0001185185-26-000010 Act: 34 Size: 203 KB
网页链接
IGC Pharma(IGC)
2025-12-16 05:05
$IGC Pharma(IGC)$
8-K Current report, items 5.03 and 9.01 Accession Number: 0001185185-25-002055 Act: 34 Size: 680 KB
网页链接
IGC Pharma(IGC)
2025-12-08 19:25
$IGC Pharma(IGC)$
EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003555 Act: 33 Size: 1 KB
网页链接
IGC Pharma(IGC)
2025-12-04 05:15
$IGC Pharma(IGC)$
S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001185185-25-001914 Act: 33 Size: 176 KB
网页链接
IGC Pharma(IGC)
2025-11-17 19:05
$IGC Pharma(IGC)$
S-3 Registration statement under Securities Act of 1933 Accession Number: 0001185185-25-001759 Act: 33 Size: 315 KB
网页链接
IGC Pharma(IGC)
2025-11-15 06:35
$IGC Pharma(IGC)$
S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001185185-25-001757 Act: 33 Size: 452 KB
网页链接
IGC Pharma(IGC)
2025-11-15 05:25
$IGC Pharma(IGC)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001185185-25-001752 Act: 34 Size: 5 MB
网页链接
IGC Pharma(IGC)
2025-11-14 23:05
$IGC Pharma(IGC)$
8-K Current report, items 2.01 and 9.01 Accession Number: 0001185185-25-001713 Act: 34 Size: 284 KB
网页链接
IGC Pharma(IGC)
2025-10-22 20:35
$IGC Pharma(IGC)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-001520 Size: 5 KB
网页链接
IGC Pharma(IGC)
2025-10-21 20:55
$IGC Pharma(IGC)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-001506 Size: 5 KB
网页链接
IGC Pharma(IGC)
2025-10-21 20:55
$IGC Pharma(IGC)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-001508 Size: 5 KB
网页链接
IGC Pharma(IGC)
2025-10-21 20:45
$IGC Pharma(IGC)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-001504 Size: 9 KB
网页链接
IGC Pharma(IGC)
2025-10-21 08:15
$IGC Pharma(IGC)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-001500 Size: 9 KB
网页链接
IGC Pharma(IGC)
2025-10-14 18:05
$IGC Pharma(IGC)$
8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001185185-25-001428 Act: 34 Size: 258 KB
网页链接
IGC Pharma(IGC)
2025-10-02 04:45
$IGC Pharma(IGC)$
8-K Current report, items 1.01 and 9.01 Accession Number: 0001185185-25-001326 Act: 34 Size: 250 KB
网页链接
IGC Pharma(IGC)
2025-09-20 04:05
$IGC Pharma(IGC)$
424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001185185-25-001235 Act: 33 Size: 306 KB
网页链接